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Abstract There is a relationship between hepatic encephalop-
athy (HE) protein malnutrition and muscle wasting. Muscle
may play an alternative role in ammonia detoxification.
Molecular mechanisms responsible for muscle depletion are
under investigation. Specific nutrients may interact to reverse
the molecular pathways involved inmuscle wasting at an early
stage. Training exercises have also been proposed to improve
skeletal muscle mass. However, these data refer to small
groups of patients. The amelioration of muscle mass may po-
tentially help to prevent HE. The pathogenesis of HE is asso-
ciated with modifications of the gut microbiota and diet is
emerging to play a relevant role in the modulation of the gut
milieu. Vegetarian and fibre-rich diets have been shown to
induce beneficial changes on gut microbiota in healthy people,
with reduction of Bacteroides spp., Enterobacteriaceae, and
Clostridium cluster XIVa bacteria. By way of contrast, it has
been suggested that a high-fat or protein diet may increase
Firmicutes and reduce Bacteroidetes phylum. Milk-lysozyme
and milk-oligosaccharides have also been proposed to induce
a Bhealthy^ microbiota. At present, no studies have been pub-
lished describing the modification of the gut microbiota in
cirrhotic patients with HE as a response to specific diets.
New research is needed to evaluate the potentiality of foods
in the modulation of gut microbiota in liver disease and HE.
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Malnutrition and HE: what correlation?
Hepatic encephalopathy (HE), together with malnutrition, are
among the most frequent complications of liver cirrhosis and
upcoming evidence suggests that theymay be strictly connect-
ed. Indeed, protein malnutrition represents an independent
prognostic factor for survival in patients with liver cirrhosis
(Merli et al. 1996; Montano-Loza et al. 2012) and is associat-
ed with a higher frequency of complications. In a vast series of
cirrhotic patients, episodes of hepatic encephalopathy (HE)
were reported only in those with a protein-malnutrition diag-
nosis (Huisman et al. 2011). Furthermore, in a recent prospec-
tive study cirrhotic patients with muscle depletion were those
at higher risk of both minimal and overt HE (Merli et al.
2013a).
The rationale for the relationship between muscle and HE
is based on the role played bymuscle in ammonia metabolism.
Due to the inability of the failing liver to affect urea synthesis,
the muscle plays a crucial role in ammonia detoxification by
glutamine synthesis (Olde Damink et al. 2002). Although this
metabolic pathway does not result in a definitive ammonia
disposal, it has been proposed that muscle depletion may have
relevant implications in favouring HE (Wright et al. 2011).
From this point of view, amelioration of nutritional status
needs to be considered an effective goal to improve the cog-
nitive impairment in these patients. As a consequence, modu-
lation of diet may be considered a promising option when
seeking to prevent HE.
European and American Clinical practice guidelines pro-
vide clear statements regarding nutritional care in cirrhotic
patients (Vilstrup et al. 2014) underlining the fact that the main
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aim of the nutritional support in the presence of liver cirrhosis
is to avoid malnutrition and prevent muscle wasting by main-
taining an adequate calorie and protein intake. However, in
spite of these indications, muscle wasting is still reported in
40–76 % of these patients (Montano-Loza et al. 2012; Giusto
et al. 2015; Tandon et al. 2012). It is likely that the dietary
approach needs to be associated with something else.
Diet to prevent muscle wasting: should we add
something else?
Knowledge concerning the molecular mechanisms involved
in muscle wasting has increased, mainly following studies on
experimental models, while few data have appeared regarding
cirrhotic patients. Myostatin has been shown to play a central
role as a negative regulator of muscle mass although contro-
versial results have been published on muscle biopsies from
cirrhotic patients (Qiu et al. 2013; Merli et al. 2013b).
Experimental models of biliary cirrhosis (Shih-Yi Lin et al.
2004) suggest that the ubiquitin-proteasome system, which
becomes hyper-activated in catabolic states associated with
muscle depletion, may be involved in skeletal muscle deple-
tion. However, Porto-caval shunt and muscle biopsies from
cirrhotic patients seem to suggest that the expression of critical
proteasome components such as MuRF1 and atrogin were
unaltered, while expression of autophagy markers have been
shown to increase significantly (Dasarathy et al. 2004;
Dasarathy et al. 2007¸ Qiu et al. 2012). An opportunity to
explore the issue is provided by supplementing the patient’s
diet with something capable of counteracting the molecular
mechanisms involved in sarcopenia.
In a recent paper, Dasarathy et al. investigated the effect of
a single oral branched chain amino acid mixture enriched with
leucine (BCAA/LEU) on a small group of alcoholic patients
with cirrhosis. Muscle biopsies were obtained before and 7 h
after BCAA/LEU administration. Although the supplementa-
tion did not modify the myostatin expression, autophagy
markers decreased while the mammalian target of rapamycin
(mTOR), regulating protein synthesis, was activated. These
data are interesting because they show the potentially positive
effect of BCAA/LEU dietary supplementation on the molec-
ular mechanisms responsible for muscle depletion in liver cir-
rhosis (Tsien et al. 2015). Nevertheless, the interpretation of
the results is limited by the lack of an appropriate control
group receiving a comparable nitrogen load.
Another possibility to take into consideration is the associ-
ation of exercise training and a balanced oral diet. In fact
training is known to exert a positive effect on muscle mass
even in patients with chronic diseases (Zinna and Yarasheski
2003).
In a recent prospective pilot study by Zenith et al., eight
weeks of supervised aerobic exercise training increased
muscle mass, expressed as thigh circumference, and reduced
fatigue in 8 patients with Child-Pugh class A or B cirrho-
sis (Zenith et al. 2014). Another recent randomized pilot
study including cirrhotic patients, Child-Pugh grade A or
B, examined whether an exercise programme combined
with leucine supplementation might improve patient out-
come over a period of 12 weeks. At the end of the period
the authors reported that the intervention group (8 patients)
had improved their exercise capacity (evaluated through a
6 min walk test and 2 min step test) and muscle mass
(expressed as lower thigh circumference) (Román et al.
2014).
These results, although based on a small series, suggest that
a combined diet, nutritional-supplementation and exercise ap-
proachmay lead to an improvement in skeletal muscle mass in
cirrhotic patients.
Whether the amelioration of muscle mass can reduce or
even prevent episodes of HE has not been evaluated and needs
to be explored by future studies.
The influence of diet on microbiota: one possible
mode of HE prevention or treatment
In recent years attention has been focused on gut microbiota
and its pathogenic role in the development of systemic inflam-
mation, endotoxemia, and portal vasodilation leading to the
main complications involved in liver cirrhosis such as HE
(Bajaj et al. 2014). A limited number of studies investigating
the gut-liver-brain axis in cirrhosis have proposed that gut
microbiome composition may impact on the neurocognitive
function (Bajaj 2014; Rai et al. 2015). By sequencing bacterial
the 16S rDNA gene from the faeces of cirrhotic patients with
and without minimal HE (MHE), Zhang and colleagues ob-
served an abundance of Streptococcaceae and Veillonellaceae
in cirrhotic patients vs normal individuals. At the same time,
they reported that the gut urease-containing species
Streptococcus salivarius was present only in cirrhotic patients
and not in control subjects. The abundance of Streptococcus
salivarius was significantly higher in cirrhotic subjects with
MHE respect to those without MHE and was found to be
correlated with ammonia levels (Zhang et al. 2013). By way
of contrast, Bajaj and coauthors, analyzing the stool microbi-
ota of cirrhotic patients with or without overt HE failed to find
significant differences. However, when the colonic mucosa
microbiota was investigated, these authors observed a number
of differences between patients with and without overt HE.
Specifically, Firmicutes phylum and members of Veillonella,
Megasphaera, Bifidobacterium, and Enterococcus genera
were higher in the HE group, whereas Roseburia was more
abundant in the non-HE group (Bajaj et al. 2012).
The identification of a close connection between the gut
microbiota, the liver and the brain, together with the
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awareness that diet may play a crucial role in the regulation of
the gut milieu, led to the hypothesis that modulation of the gut
microbiota through changes in the quality of food assumption
may be a potential therapeutic target for HE.
One of the first studies, aimed at investigating whether
a dietary supplement capable of modulating gut microbiota
might prove useful in the treatment of MHE and preven-
tion of overt HE, utilized a probiotic yogurt. The cirrhotic
patients were randomized to receive 12 oz of yogurt daily
in addition to dietary recommendations to follow for
60 days. MHE improved in a higher percentage of the
patients randomized to supplementation and in the same
group the occurrence of overt HE was prevented as com-
pared to the non-supplemented patients (Bajaj et al. 2008).
Many other studies have utilized the addition of prebiotics,
probiotics and symbiotics, defined as functional food com-
ponents, to daily diet for the management of HE (Amodio
et al. 2013).
Vegetarian and fibre-rich diet
Information on the effect of different diets on gut microbiota
in liver disease is still not available (Giannelli et al. 2014),
however, the idea that diet may represent a reliable alternative
therapy in the treatment of HE through modulation of the
microbiota is a really fascinating perspective. This working
hypothesis provides a new way to explain the positive effects
reported for vegetarian diets in patients with cirrhosis and HE
(Amodio et al. 2001). In the course of the past few decades it
has been claimed that vegetable proteins are better tolerated
than animal proteins in cirrhotic patients with HE (Merli et al.
2012). Some of the proposed beneficial effects are the higher
intestinal clearance of nitrogen-waste products, due to the
high-fibre content which is capable of inducing a greater bac-
terial mass, a shortened transit time, and a reduced colonic pH
entrapping ammonia in the intestinal lumen, a higher ornithine
and arginine content, which may facilitate ammonia disposal
through the urea cycle, and a lower methionine and tryptophan
content compared to animal proteins. Nowadays new
evidence suggests that additional benefits of a vegetal-
enriched diet may derive from the modulation of gut
microbiota. At present, studies evaluating the effects of
a vegetable enriched diet on gut microbiota are avail-
able only for healthy people. In a study by Zimmer
et al., a reduction in Bacteroides spp., Bifidobacterium
spp., Escherichia coli and Enterobacteriaceae was observed in
fecal samples of patients following a vegetarian/vegan diet vs
patients on an omnivorous diet (Zimmer et al. 2011). In a
cohort of vegetarian and omnivorous young women in south-
ern India, faecal microbiota was found to be enriched with
Clostridium cluster XIVa bacteria, specifically Roseburia
and E. rectale, in the omnivorous group (Kabeerdoss et al.
2012). By contrast, other authors failed to report any
differences in the microbiota composition of subjects follow-
ing the these diets (Liszt et al. 2009). The variability of the
results provided by the studies available may derive from the
heterogeneity of the population and the acknowledge that
even a vegetable enriched diet may vary in daily composition,
inducing a rapid change in the gut microbiome (David et al.
2014). New and well defined studies on the effect of
vegetarian/vegetables-enriched diets on the composition of
gut microbiota in cirrhotic patients are needed. The impact
of diets rich in whole-grain bread, cereals or rice compared
to those comprising white wheat grain have also been inves-
tigated. A diet enriched by whole grain products, with high
fibre content, seems to induce an increase in Bifidobacteria
and a reduction of Bacteroidetes in gut microbiota (Costabile
et al. 2008; Martínez et al. 2013; Lappi et al. 2013). The
microbiota of children following the low-protein, carbohy-
drate, BFiber-based diet^, typical of rural countries as opposed
to the Bprotein and polysaccharide-rich diet^ typical of the
western countries, shows a significant enrichment in
Bacteroidetes and a depletion in Firmicutes (De Filippo et al.
2010). Enterobacteriaceae (Shigella and Escherichia genera)
were also significantly lower in the BFibre-based diet^ as op-
posed to the Bprotein and polysaccharide-rich diet^.
These dietary approaches might provide an interesting op-
portunity to modulate gut microbiota in cirrhotic patients.
High fat diet
If a beneficial effect on the gut microbiota has been suggested
after the introduction of vegetables or fibres, high-fat diet has
been shown to induce a shift in the balance between the two
major phyla of gut microbiota, leading to an increase of
Firmicutes and a decrease of Bacteroidetes (Hildebrandt
et al. 2009; Turnbaugh et al. 2009). The administration of
cholic acid to rats induced phylum-level alteration in the com-
position of the gut microbiota with an increase in Firmicutes
and a reduction in Bacteroidetes, which are very similar to the
changes induced by a high-fat diet (Islam et al. 2011). Given
that bile acid secretion increases following a high-fat diet
(Reddy 1981), the authors speculated that bile acids might
be a determinant of the gut microbiota in response to a high-
fat diet (Islam et al. 2011; Yokota et al. 2012). The possible
modifications induced by a high-fat diet in cirrhotic patients
needs, therefore, also to take the alteration in biliary secretion
in these patients into account too.
Specific nutrients improving Bhealthy microbiota^
Some interesting studies have focused their attention on the
influence of specific food constituents on the promotion of Ba
healthy-microbiota^ (Maga et al. 2013; Barile and Rastall
2013). Among these food constituents, milk-lysozyme and
milk-oligosaccharides have been investigated. Lysozyme is a
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naturally occurring antimicrobial enzyme found in the
tears, saliva, and milk of all mammals that lyses a spe-
cific link in the peptidoglycan layer of bacterial cell
walls. In an experimental study, milk enriched with
68 % human lysozyme was used to feed young pigs.
This treatment induced an increase in the bacteria associated
with gut health (Bifidobacteriaceae and Lactobacillaceae) and a
decrease in those associated with diseases (Mycobacteriaceae,
Streptococcaceae, Campylobacterales) vs the control-fed group
(Maga et al. 2012). This study demonstrated that a single com-
ponent of the diet, with bioactivity, may change themicrobiome
composition of the gut. Other studies have investigated the role
of HumanMilk Oligosaccharides (HMO): HMO are being rec-
ognized as a new class of potent bioactive molecules capable of
enhancing the growth of Bifidobacteria and Lactobacilli, reduc-
ing harmful bacteria such as Clostridia, Enterococci, Eubacteria
and Enterobacteria, and preventing bacteria from attaching to
target oligosaccharides on the intestinal mucosal surface
(Fucosylated and sialylated oligosaccharides) (German et al.
2008; Bode 2012). Recent research has demonstrated that bo-
vine milk contains oligosaccharides that are analogous to HMO
and perform a similarly protective role (Zivkovic and Barile
2011). However, fluid bovine milk contains only trace amounts
of oligosaccharides; for that reason, in order to increase the
concentration of such oligosaccharides, a whey permeate has
been produced from bovine milk and has been the subject of
recent investigations. Whey permeate, further processed by
membrane filtration, may have as much as 10-fold higher total
concentrations of free oligosaccharide than bovine milk
(Zivkovic and Barile 2011) and may represent a promising
alternative as functional food to induce a healthy gut
microbiota.
All the data reported suggest that by increasing our under-
standing we will be able in the future to modulate the gut
microbiota through the introduction of specific foods or by
adopting specific diets. Fresh research in this field concerning
liver patients is required in order to understand how to take
advantage of the great potentiality of foods in the modulation
of the gut microbiota, in order to provide a therapeutic strategy
capable of treating or even of preventing complications such
as hepatic encephalopathy in those suffering from cirrhosis.
In conclusion, diet may play a central role as therapeutic
support in the treatment and prevention of HE not only by
counteracting malnutrition, but also by exerting an effect on
others pathogenic mechanisms responsible for HE. Among
these, new targets are represented by reversal of sarcopenia
and by the modulation of the gut microbiota (Fig. 1).
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